IU Simon Comprehensive Cancer Center

This month’s Simon Says Expert Series session—Earlier detection, better outcomes: A conversation on prostate cancer—will be at 12 p.m. ET Tuesday, June 23. Submit your questions and register now: https://ow.ly/wtGy50ZcPsP.

Prostate cancer is one of the most common cancers among men, but when found early, it is highly treatable. What are the signs? Who should be screened? And how can early detection make a difference?

In this Simon Says session, Clint Bahler, MD, a urologist and prostate cancer researcher, leads a conversation on prevention, screening, and early diagnosis. He’ll be joined by moderator Gene Wurth, a grateful patient, who brings a personal perspective to the discussion.

Together, they’ll share what every man should know about prostate health and what partners, family members, and caregivers can do to encourage screening and support early action. Whether you’re thinking about your own health or someone you love, this session offers practical insights during Men’s Health Month.

A major honor for one of Indiana University's research leaders.

The cancer center’s Reuben Kapur, PhD, has been named an IU Indianapolis Chancellor’s Professor.

This distinction is the highest faculty appointment at IU Indianapolis and recognizes excellence in research, teaching and service.

Read more about Dr. Kapur’s recognition and contributions to advancing science and discovery: https://ow.ly/PCfJ50Z4JvU.

Nabil Adra, MD, has been named the Rikki and Leonard Goldstein Scholar in Cancer Research at Indiana University School of Medicine.

Dr. Adra focuses on urologic oncology, treating prostate, testicular, bladder and kidney cancers. He contributed to a multi-year clinical trial that led to FDA approval of a new combination therapy, offering the potential to cure more patients with bladder cancer.

This professorship honors the legacy of Rikki and Leonard “Len” Goldstein, whose longtime support of Indiana University continues to advance cancer research and expand treatment options for patients.

Please join us in congratulating Dr. Adra on this recognition.